Cost-effectiveness analysis of a first-trimester screening test for preterm preeclampsia in the Netherlands

Objectives: The risk of preterm preeclampsia (PT PE) can significantly be reduced by starting acetylsalicylic acid ≤ 16 weeks of gestational age. First trimester predictive models based on maternal risk factors to effectively start this therapy lacked sufficient power, but recent studies showed that these models can be improved by including test results of biochemical and/or -physical markers. To investigate whether testing a biochemical marker in the first trimester is cost-effective in the Netherlands, a cost-effectiveness analysis was performed in this study. Study design: The outcome of th... Mehr ...

Verfasser: Beernink, Rik H. J.
Scherjon, Sicco A.
Cremers, Thomas I. F. H.
van Asselt, Antoinette D.I.
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Reihe/Periodikum: Beernink , R H J , Scherjon , S A , Cremers , T I F H & van Asselt , A D I 2023 , ' Cost-effectiveness analysis of a first-trimester screening test for preterm preeclampsia in the Netherlands ' , Journal of Reproductive Immunology , vol. 160 , 104141 . https://doi.org/10.1016/j.jri.2023.104141
Schlagwörter: Cost-effectiveness analysis / Netherlands / Preterm preeclampsia
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26824874
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://hdl.handle.net/11370/2ca5ba35-c42e-4001-96f1-d7e5ef758334